TOMS RIVER – CenExel Toms River NJ, a leader in advancing clinical research, is committed to addressing the significant gender disparities in Alzheimer’s disease (AD). New findings highlight that women are more likely to develop AD compared to men, underscoring the urgent need for targeted research and treatment.
Alzheimer’s disease affects nearly 7 million Americans aged 65 and older, with women comprising almost two-thirds of this population. Women in their 60s are twice as likely to develop Alzheimer’s over the course of their lives as they are to develop breast cancer.
The reasons behind gender disparity are multifaceted, encompassing biological, genetic, and social factors. While women’s longer life expectancy has traditionally been citing as a key factor, emerging research suggests that other variables, such as hormonal changes and difference in brain architecture, may also contribute.
In addition to being disproportionately affected by Alzheimer’s, women are also more likely to serve as caregivers for those living with AD. More than 60% of Alzheimer’s and dementia caregivers are women, with over one-third being daughters. Women caregivers often take on more demanding tasks and care for individuals with greater cognitive and behavioral challenges.
“Women are at the forefront of the Alzheimer’s crisis.” Said Anna Brocco, PharmD, MBA, site Chief Operating Officer. “At CenExel Toms River, we acknowledge this reality and offer comprehensive support to women battling this disease, whether as patients or caregivers. We provide access to advanced research opportunities and a dedicated caregiver support group for those seeking a compassionate ear.”
CenExel Toms River invites the community to join its efforts in raising awareness and supporting Alzheimer’s research. For more information about their ongoing trials and how to get involved, please visit CenExel.com/AMRI or call 732-908-1510.
About CenExel Toms River NJ
CenExel Toms River is dedicated to advancing medical research through clinical trials focusing on memory loss and related conditions. Leveraging a state-of-the-art facility and a team of experienced clinicians, CenExel Toms River ensures high standards in clinical trial execution and patient-focused care.
The post CenExel Toms River Sheds Light On Gender Disparities In Alzheimer’s Disease appeared first on Jersey Shore Online.